# Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium

> **NCT01885715** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 112 (actual)

## Conditions studied

- Observation of Neuromuscular Block

## Interventions

- **DRUG:** Injection of neostigmine

## Key facts

- **NCT ID:** NCT01885715
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2014-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01885715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01885715, "Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01885715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*